Shabsis v. Advocate Capital CA2/2

CourtCalifornia Court of Appeal
DecidedJuly 1, 2024
DocketB330362
StatusUnpublished

This text of Shabsis v. Advocate Capital CA2/2 (Shabsis v. Advocate Capital CA2/2) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Shabsis v. Advocate Capital CA2/2, (Cal. Ct. App. 2024).

Opinion

Filed 7/1/24 Shabsis v. Advocate Capital CA2/2 NOT TO BE PUBLISHED IN THE OFFICIAL REPORTS

California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

SECOND APPELLATE DISTRICT

DIVISION TWO

MICHAEL SHABSIS et al., B330362

Plaintiffs and Appellants, (Los Angeles County Super. Ct. No. v. 19STCV30802)

ADVOCATE CAPITAL, INC., et al.,

Defendants and Respondents.

APPEAL from an order of the Superior Court of Los Angeles County, Wendy Chang, Judge. Affirmed.

Law Offices of Michael J. Libman and Michael J. Libman for Plaintiffs and Appellants. Wilson, Elser, Moskowitz, Edelman & Dicker, David S. Eisen, and Adam LeBerthon for Defendants and Respondents Advocate Capital, Inc., Wellgen Standard, LLC, Paul Myers, Michael Swanson, and Dan Taussig.

Bird, Marella, Boxer, Wolpert, Nessim, Drooks, Licenberg & Rhow, Mark T. Drooks, and Sharon Mayer for Defendant and Respondent Bradley Arant Boult Cummings, LLP.

****** The trial court granted a motion to strike several malicious prosecution-related claims under our anti-SLAPP1 law (Code Civ. Proc., § 425.16)2. Because this was undoubtedly correct, we affirm. FACTS AND PROCEDURAL BACKGROUND I. Lender Obtains an Interest in Lawyer’s Anticipated Recovery Lisa Maki (Maki) was a California attorney who financed some of her litigation expenses through loans from Advocate Capital, Inc. (Advocate), a specialized lender. In exchange for those cash advances, Maki—by written agreements in 2010 and 2015—granted Advocate a “continuing security interest” in her present and future rights to receive payments for her legal services in any client matter.

1 “SLAPP” is short for “strategic lawsuit against public participation.”

2 All further statutory references are to the Code of Civil Procedure unless otherwise indicated.

2 Maki did not repay her outstanding loan balance, which approached $1 million by 2018. II. Lawyer Has Potential Right to Payment in Personal Injury Lawsuit A. Lawyer joins as cocounsel in the Shabsis lawsuit On Christmas Eve 2014, Michael Shabsis (Shabsis) sued the pharmaceutical company Pfizer Inc. (Pfizer) and the County of Los Angeles (the County), among other parties, for $35 million in injuries he inflicted upon himself while in a “delusional” state in jail after taking a Pfizer medication to stop smoking. Initially, Shabsis’s lawyer was Michael J. Libman (Libman). In March 2017, Maki became cocounsel for Shabsis. Maki was to be paid on a contingency fee basis; with Shabsis’s consent, she and Libman entered into an agreement to split fees. B. Lawyer withdraws as counsel On August 21, 2018, the State Bar of California ordered Maki to be “involuntarily enrolled as an inactive member” pending proceedings against her for various ethical violations. One week letter, Maki withdrew as counsel for Shabsis in his lawsuit.3 C. Lawyer asserts lien against proceeds in Shabsis lawsuit On October 12, 2018, Maki served Pfizer and the County with a notice of lien for $807,278.68 in attorney fees for the work she had performed on Shabsis’s case. D. Resolution of Shabsis lawsuit Pfizer settled with Shabsis for an undisclosed amount. Shabsis continued to litigate against the County; the trial court

3 Maki was disbarred on December 1, 2019.

3 dismissed several of his claims on summary adjudication,4 and the jury rejected the remainder after a trial. III. Lender Tries to Collect on Lawyer’s Right to Payment in Shabsis Lawsuit Upon learning that Maki had a potential right to payment in the Shabsis lawsuit, Advocate notified Libman, Pfizer, and the County that any payments owed to Maki should instead be directed to Advocate, and requested a copy of the fee-sharing agreement between Libman and Maki. No one cooperated. Libman responded that, despite Maki’s asserted lien, Maki was owed nothing from the Shabsis case because she withdrew as counsel; that any fee-sharing agreement he had with Maki was privileged; and that he would not set aside funds in an escrow account pending resolution of the matter. Pfizer refused to disburse any settlement funds to Shabsis until the attorney fees lien was resolved. Maki was simply nonresponsive. IV. Lender Sues for Declaratory Relief in Federal Court Stymied in its efforts to obtain information about Maki’s entitlement to the proceeds in the Shabsis matter, Advocate on April 16, 2019 brought a declaratory relief action in federal court against Libman, Maki, and Shabsis regarding the amount and validity of Maki’s attorney fees lien (the federal action). Maki filed a counterclaim against Libman, alleging Libman had not paid “any portion of her fees and costs” she was owed in the Shabsis matter. Libman and Shabsis filed a responsive

4 Shabsis blames those rulings on Maki’s allegedly “sub- standard, negligent, incompetent work.”

4 counterclaim, alleging Maki was entitled to nothing and had intentionally caused Shabsis emotional distress.5 Soon thereafter, Maki moved abroad and affirmatively disclaimed any intention of collecting on her lien in the Shabsis matter. Within four weeks of learning of Maki’s disclaimer, Advocate voluntarily dismissed the federal action against Libman and Shabsis with prejudice.6 V. Current Action for Malicious Prosecution of the Federal Action A. Pleadings In an amended complaint filed on February 25, 2021,7 Libman and Shabsis (collectively, plaintiffs) sued Advocate, certain entities and executives affiliated with Advocate, and the law firm that represented Advocate in the federal action (collectively, Advocate)8 for (1) malicious prosecution, (2)

5 Libman and Shabsis also counterclaimed against Advocate, but those counterclaims were dismissed.

6 By that time, Advocate had prevailed on summary judgment against Maki in a separate action to enforce the loan agreement, and obtained a judgment of $1,043,349.58. Libman and Shabsis also obtained a default judgment against Maki for $182,700 plus fees and costs.

7 The original complaint filed on August 28, 2019 did not name Advocate or include any malicious prosecution allegations.

8 The other entities named as defendants are (1) ACF 2006 Corp., which was assigned Advocate’s interest in the agreement with Maki and which later merged into Advocate; and (2) Wellgen Standard, LLC (Wellgen), which had an ownership interest in Advocate until 2019.

5 wrongful use of civil proceedings, and (3) engaging in a civil conspiracy with Maki to maliciously prosecute—all with respect to the federal action. Plaintiffs alleged that Advocate’s federal action was a “shakedown” intended to tie up Shabsis’s settlement funds. B. Anti-SLAPP motion On September 9, 2022, Advocate filed a motion to strike the claims against it under the anti-SLAPP law. Following full briefing and a hearing, the trial court granted the anti-SLAPP motion. As a threshold matter, the court denied plaintiffs’ request, made for the first time in their opposition brief, to conduct discovery into an advice-of-counsel defense because there was no indication in the record that Advocate was relying on such a defense.9 On the merits, the trial court ruled that plaintiffs’ claims against Advocate involved activity protected by the anti-SLAPP law because those claims arose out of Advocate’s prosecution of

The executives named as defendants are (1) Paul Myers, Advocate’s CEO and former Chief Credit Officer; (2) Daniel Taussig, the CEO of Wellgen and former chairman of the board of Advocate; and (3) Michael Swanson, President of Wellgen and former CEO of Advocate.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Oasis West Realty v. Goldman
250 P.3d 1115 (California Supreme Court, 2011)
Trapp v. Naiman CA4/2
218 Cal. App. 4th 113 (California Court of Appeal, 2013)
Duchrow v. Forrest
215 Cal. App. 4th 1359 (California Court of Appeal, 2013)
Sheldon Appel Co. v. Albert & Oliker
765 P.2d 498 (California Supreme Court, 1989)
Bogacki v. Board of Supervisors
489 P.2d 537 (California Supreme Court, 1971)
Estate of Falco
188 Cal. App. 3d 1004 (California Court of Appeal, 1987)
Platypus Wear, Inc. v. Goldberg
166 Cal. App. 4th 772 (California Court of Appeal, 2008)
Hutton v. HAFIF
59 Cal. Rptr. 3d 109 (California Court of Appeal, 2007)
Barak v. the Quisenberry Law Firm
37 Cal. Rptr. 3d 688 (California Court of Appeal, 2006)
Daniels v. Robbins
182 Cal. App. 4th 204 (California Court of Appeal, 2010)
Rus, Miliband & Smith v. Conkle & Olesten
6 Cal. Rptr. 3d 612 (California Court of Appeal, 2003)
Paiva v. Nichols
168 Cal. App. 4th 1007 (California Court of Appeal, 2008)
Sierra Club Foundation v. Graham
85 Cal. Rptr. 2d 726 (California Court of Appeal, 1999)
Padres L.P. v. Henderson
8 Cal. Rptr. 3d 584 (California Court of Appeal, 2004)
Rogers v. Home Shopping Network, Inc.
57 F. Supp. 2d 973 (C.D. California, 1999)
Navellier v. Sletten
52 P.3d 703 (California Supreme Court, 2002)
Equilon Enterprises v. Consumer Cause, Inc.
52 P.3d 685 (California Supreme Court, 2002)
Rusheen v. Cohen
128 P.3d 713 (California Supreme Court, 2006)
Zamos v. Stroud
87 P.3d 802 (California Supreme Court, 2004)
Wilson v. Parker, Covert & Chidester
50 P.3d 733 (California Supreme Court, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
Shabsis v. Advocate Capital CA2/2, Counsel Stack Legal Research, https://law.counselstack.com/opinion/shabsis-v-advocate-capital-ca22-calctapp-2024.